News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome Joint research effort will lead to molecular assays that can improve variant detection and access difficult-to-sequence regions of the human genome Read more
Company extends program benefits to oncology laboratories and fast-tracks access to comprehensive molecular profiling on the Genexus System CARLSBAD, Calif., July 27, 2020 /PRNewswire/ — Thermo Fisher Scientific today announced the expansion of its GlobalAccess Sequencing Program to include laboratories working in oncology. Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2, the expanded program now... Read more
Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity Validated with Bruker-Hain GenoXtract® NA and GenoXtract® 96 X3 nucleic acid extraction system and kits Validated with novel Bruker-Hain FluoroCycler® XT real-time PCR thermocycler NEHREN, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today... Read more
MINNEAPOLIS, July 21, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has completed validation testing for COVID-19 caused by the novel coronavirus (SARS-CoV-2) and now offers the ExoCovid-19 test for detection of the virus in patient samples. The ExoCovid-19 test will be performed in its CLIA-certified, CAP-accredited laboratory. Exosome Diagnostics, the... Read more
Expanding research tools to detect small non-coding RNAs in situ by combining molecular information with spatial context. MINNEAPOLIS, July 20, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the RNAscope™ platform with the release of the miRNAscope™ Assay. The RNAscope technology is an advanced in situ hybridization assay for the spatial visualization... Read more
EDEN PRAIRIE, Minn., July 20, 2020 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems, motion simulators and precision sensors, today announced that it will release its third quarter results on August 3, 2020 after market close. A conference call will be held on August 4, 2020 at 11:00... Read more
AUSTIN, Texas, July 20, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2020 on Tuesday, August 4, 2020. A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference... Read more
Brooks Automation Announces Third Quarter Fiscal 2020 Earnings Conference Call and Webcast CHELMSFORD, Mass., July 17, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2020 third quarter earnings which ended on June 30, 2020 on Thursday, July 30, 2020 after the market closes. The Company will host a conference call and live webcast... Read more
Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more
WASHINGTON, July 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more